Bicara Therapeutics BCAX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bicara Therapeutics's financing cash flow?
- Bicara Therapeutics (BCAX) reported financing cash flow of $163.35M in Q1 2026.
- How has Bicara Therapeutics's financing cash flow changed year-over-year?
- Bicara Therapeutics's financing cash flow increased by 35409.8% year-over-year, from $460K to $163.35M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.